Selected research
Industry Research
Molecular Diagnostics Raw Material Industry Research Report 2026
Market perspective
The global Molecular Diagnostics Raw Material market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Molecular Diagnostics Raw Material market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Molecular Diagnostics Raw Material market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Molecular Diagnostics Raw Material market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Molecular Diagnostics Raw Material include Agilent, Bio-Rad, Fapon Biotech, New England Biolabs, Promega, Qiagen, Takara Bio, TOYOBO Biotech and Fapon Biotech Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Molecular Diagnostics Raw Material market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Molecular Diagnostics Raw Material.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Molecular Diagnostics Raw Material Market by Company
Agilent
Bio-Rad
Fapon Biotech
New England Biolabs
Promega
Qiagen
Takara Bio
TOYOBO Biotech
Fapon Biotech Inc
Roche
Vazyme
Thermo Fisher
Molecular Diagnostics Raw Material Segment by Type
DNA Polymerase
PCR Excipients
Reverse Transcriptase
Other
Molecular Diagnostics Raw Material Segment by Application
scientific Research
Disease Diagnosis
Adjuvant Therapy
Molecular Diagnostics Raw Material Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molecular Diagnostics Raw Material market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Molecular Diagnostics Raw Material and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molecular Diagnostics Raw Material.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Molecular Diagnostics Raw Material companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- DNA Polymerase
- PCR Excipients
- Reverse Transcriptase
- Other
Applications
- scientific Research
- Disease Diagnosis
- Adjuvant Therapy
Companies covered
- Agilent
- Bio-Rad
- Fapon Biotech
- New England Biolabs
- Promega
- Qiagen
- Takara Bio
- TOYOBO Biotech
- Fapon Biotech Inc
- Roche
- Vazyme
- Thermo Fisher
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Molecular Diagnostics Raw Material by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 DNA Polymerase
- 2.2.3 PCR Excipients
- 2.2.4 Reverse Transcriptase
- 2.2.5 Other
- 2.3 Molecular Diagnostics Raw Material by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 scientific Research
- 2.3.3 Disease Diagnosis
- 2.3.4 Adjuvant Therapy
- 2.4 Assumptions and Limitations
3 Molecular Diagnostics Raw Material Breakdown Data by Type
- 3.1 Global Molecular Diagnostics Raw Material Historic Market Size by Type (2021-2026)
- 3.2 Global Molecular Diagnostics Raw Material Forecasted Market Size by Type (2027-2032)
4 Molecular Diagnostics Raw Material Breakdown Data by Application
- 4.1 Global Molecular Diagnostics Raw Material Historic Market Size by Application (2021-2026)
- 4.2 Global Molecular Diagnostics Raw Material Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Molecular Diagnostics Raw Material Market Perspective (2021-2032)
- 5.2 Global Molecular Diagnostics Raw Material Growth Trends by Region
- 5.2.1 Global Molecular Diagnostics Raw Material Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Molecular Diagnostics Raw Material Historic Market Size by Region (2021-2026)
- 5.2.3 Molecular Diagnostics Raw Material Forecasted Market Size by Region (2027-2032)
- 5.3 Molecular Diagnostics Raw Material Market Dynamics
- 5.3.1 Molecular Diagnostics Raw Material Industry Trends
- 5.3.2 Molecular Diagnostics Raw Material Market Drivers
- 5.3.3 Molecular Diagnostics Raw Material Market Challenges
- 5.3.4 Molecular Diagnostics Raw Material Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Molecular Diagnostics Raw Material Players by Revenue
- 6.1.1 Global Top Molecular Diagnostics Raw Material Players by Revenue (2021-2026)
- 6.1.2 Global Molecular Diagnostics Raw Material Revenue Market Share by Players (2021-2026)
- 6.2 Global Molecular Diagnostics Raw Material Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Molecular Diagnostics Raw Material Head Office and Area Served
- 6.4 Global Molecular Diagnostics Raw Material Players, Product Type & Application
- 6.5 Global Molecular Diagnostics Raw Material Manufacturers Established Date
- 6.6 Global Molecular Diagnostics Raw Material Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Molecular Diagnostics Raw Material Market Size (2021-2032)
- 7.2 North America Molecular Diagnostics Raw Material Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Molecular Diagnostics Raw Material Market Size by Country (2021-2026)
- 7.4 North America Molecular Diagnostics Raw Material Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Molecular Diagnostics Raw Material Market Size (2021-2032)
- 8.2 Europe Molecular Diagnostics Raw Material Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Molecular Diagnostics Raw Material Market Size by Country (2021-2026)
- 8.4 Europe Molecular Diagnostics Raw Material Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Molecular Diagnostics Raw Material Market Size (2021-2032)
- 9.2 Asia-Pacific Molecular Diagnostics Raw Material Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Molecular Diagnostics Raw Material Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Molecular Diagnostics Raw Material Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Molecular Diagnostics Raw Material Market Size (2021-2032)
- 10.2 South America Molecular Diagnostics Raw Material Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Molecular Diagnostics Raw Material Market Size by Country (2021-2026)
- 10.4 South America Molecular Diagnostics Raw Material Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Molecular Diagnostics Raw Material Market Size (2021-2032)
- 11.2 Middle East & Africa Molecular Diagnostics Raw Material Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Molecular Diagnostics Raw Material Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Molecular Diagnostics Raw Material Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Agilent
- 12.1.1 Agilent Company Information
- 12.1.2 Agilent Business Overview
- 12.1.3 Agilent Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.1.4 Agilent Molecular Diagnostics Raw Material Product Portfolio
- 12.1.5 Agilent Recent Developments
- 12.2 Bio-Rad
- 12.2.1 Bio-Rad Company Information
- 12.2.2 Bio-Rad Business Overview
- 12.2.3 Bio-Rad Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.2.4 Bio-Rad Molecular Diagnostics Raw Material Product Portfolio
- 12.2.5 Bio-Rad Recent Developments
- 12.3 Fapon Biotech
- 12.3.1 Fapon Biotech Company Information
- 12.3.2 Fapon Biotech Business Overview
- 12.3.3 Fapon Biotech Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.3.4 Fapon Biotech Molecular Diagnostics Raw Material Product Portfolio
- 12.3.5 Fapon Biotech Recent Developments
- 12.4 New England Biolabs
- 12.4.1 New England Biolabs Company Information
- 12.4.2 New England Biolabs Business Overview
- 12.4.3 New England Biolabs Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.4.4 New England Biolabs Molecular Diagnostics Raw Material Product Portfolio
- 12.4.5 New England Biolabs Recent Developments
- 12.5 Promega
- 12.5.1 Promega Company Information
- 12.5.2 Promega Business Overview
- 12.5.3 Promega Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.5.4 Promega Molecular Diagnostics Raw Material Product Portfolio
- 12.5.5 Promega Recent Developments
- 12.6 Qiagen
- 12.6.1 Qiagen Company Information
- 12.6.2 Qiagen Business Overview
- 12.6.3 Qiagen Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.6.4 Qiagen Molecular Diagnostics Raw Material Product Portfolio
- 12.6.5 Qiagen Recent Developments
- 12.7 Takara Bio
- 12.7.1 Takara Bio Company Information
- 12.7.2 Takara Bio Business Overview
- 12.7.3 Takara Bio Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.7.4 Takara Bio Molecular Diagnostics Raw Material Product Portfolio
- 12.7.5 Takara Bio Recent Developments
- 12.8 TOYOBO Biotech
- 12.8.1 TOYOBO Biotech Company Information
- 12.8.2 TOYOBO Biotech Business Overview
- 12.8.3 TOYOBO Biotech Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.8.4 TOYOBO Biotech Molecular Diagnostics Raw Material Product Portfolio
- 12.8.5 TOYOBO Biotech Recent Developments
- 12.9 Fapon Biotech Inc
- 12.9.1 Fapon Biotech Inc Company Information
- 12.9.2 Fapon Biotech Inc Business Overview
- 12.9.3 Fapon Biotech Inc Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.9.4 Fapon Biotech Inc Molecular Diagnostics Raw Material Product Portfolio
- 12.9.5 Fapon Biotech Inc Recent Developments
- 12.10 Roche
- 12.10.1 Roche Company Information
- 12.10.2 Roche Business Overview
- 12.10.3 Roche Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.10.4 Roche Molecular Diagnostics Raw Material Product Portfolio
- 12.10.5 Roche Recent Developments
- 12.11 Vazyme
- 12.11.1 Vazyme Company Information
- 12.11.2 Vazyme Business Overview
- 12.11.3 Vazyme Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.11.4 Vazyme Molecular Diagnostics Raw Material Product Portfolio
- 12.11.5 Vazyme Recent Developments
- 12.12 Thermo Fisher
- 12.12.1 Thermo Fisher Company Information
- 12.12.2 Thermo Fisher Business Overview
- 12.12.3 Thermo Fisher Revenue in Molecular Diagnostics Raw Material Business (2021-2026)
- 12.12.4 Thermo Fisher Molecular Diagnostics Raw Material Product Portfolio
- 12.12.5 Thermo Fisher Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst